FMP
Helix BioPharma Corp.
HBP.TO
TSX
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada.
0.175 CAD
-0.025 (-14.29%)
About
ceo
Mr. Jacek Antas
sector
Healthcare
industry
Biotechnology
website
https://www.helixbiopharma.com
exchange
TSX
Description
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered ...
CIK
N/A
ISIN
CA4229101098
CUSIP
422910109
Address
9120 Leslie Street
Phone
905 841 2300
Country
CA
Employee
9
IPO Date
Aug 13, 1996
Summary
CIK
-
Exchange
TSX
Industry
Biotechnology
Sector
Healthcare
CUSIP
422910109
ISIN
CA4229101098
Country
CA
Price
0.17
Beta
-0.73
Volume Avg.
12.81k
Market Cap
37.92M
Shares
-
52-Week
0.15-0.26
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-5.83
P/B
-
Website
https://www.helixbiopharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest HBP.TO News
It looks like there's no news available.
